Tue, May 8, 2018
Mon, May 7, 2018
Fri, May 4, 2018
Thu, May 3, 2018
Wed, May 2, 2018
Tue, May 1, 2018
Mon, April 30, 2018
Fri, April 27, 2018
Thu, April 26, 2018

Robyn Karnauskas Maintained (BIIB) at Hold with Decreased Target to $290 on, May 2nd, 2018


//stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-290-on-may-2nd-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Robyn Karnauskas of Citigroup, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $360 to $290 on, May 2nd, 2018.

Robyn has made no other calls on BIIB in the last 4 months.



There are 9 other peers that have a rating on BIIB. Out of the 9 peers that are also analyzing BIIB, 2 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Downgraded from Buy to Hold on, Thursday, April 5th, 2018
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $350 on, Wednesday, January 24th, 2018


These are the ratings of the 7 analyists that currently disagree with Robyn


  • Brian Skorney of "Baird" Upgraded from Hold to Buy on, Wednesday, April 25th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $369 on, Wednesday, April 25th, 2018
  • Ian Somaiya of "BMO Capital" Maintained at Buy with Decreased Target to $393 on, Monday, March 5th, 2018
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $433 on, Monday, February 5th, 2018
  • Carter Gould of "UBS" Upgraded from Hold to Strong Buy on, Wednesday, January 31st, 2018
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Friday, January 26th, 2018
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $363 on, Friday, January 26th, 2018

Publication Contributing Sources